The expression of PD-L1 was abundant (tumor proportion score [TPS] ≥ 50%) in 42 patients (26.8%), at low levels (1% ≤ TPS < 50%) in 29 patients (18.5%), and unknown in the remaining 86 (54.8%). The gene discussed is CD274; the disease is neoplasm.